Senseonics, Beta Bionics Partner on Eversense 365-iLet Diabetes System

07:48 AM EDT, 09/14/2026 (MT Newswires) -- Senseonics (SENS) has partnered with Beta Bionics (BBNX) to integrate its Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas automated insulin delivery system, the company said Monday. The companies plan to combine Eversense 365's year-long glucose sensing with iLet's adaptive insulin delivery, without requiring users to count carbohydrates. Senseonics expects the integration to be completed in Q4, with a commercial launch planned for the quarter, it added. Senseonics shares rose 1.3% in premarket trading while Beta Bionics shares fell 3%.